Castration-resistant Prostate Cancer
📧 Sign up to get email alerts when something new happens for Castration-resistant Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. [NA]
Continuation study of sunitinib malate for patients who left a prior sunitinib trial; completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study evaluating the combination of cabazitaxel and abiraterone acetate in patie…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 study evaluating novel scheduling of cabazitaxel for metastatic castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer [Phase 2]
A Phase 2 clinical trial investigating exogenous testosterone plus dutasteride for metastatic castration-resistant prostate cancer has compl…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer [Phase 3]
Phase 3 study of tasquinimod in men with metastatic castration-resistant prostate cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity
A completed clinical trial evaluating whether lean body mass influences the pharmacokinetics and toxicity of docetaxel. The study involved p…
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC [Phase 1]
Phase 1 clinical trial update for GEN0101 in patients with recurrent castration-resistant prostate cancer; the trial status is currently unk…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer [Phase 1, Phase 2]
This is an update on a Phase 1-2 trial of onapristone in patients with advanced castration-resistant prostate cancer, with the current statu…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update reporting safety and efficacy results for pertuzumab in castration-resistant prostate cancer.
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC
This completed clinical trial reports on the duration of suppression of bone turnover after treatment with zoledronic acid in men with metas…
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 3]
Phase 3 trial results for abiraterone acetate in asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer are post…
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel [Phase 2]
A completed Phase 2 study evaluating ILX651 in patients with castration-resistant prostate cancer who were previously treated with docetaxel…
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]
This update reports results from a Phase I/II study of TRC105 in metastatic castration-resistant prostate cancer. The trial has completed an…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate [Phase 2]
This Phase 2 trial evaluated a combination of estramustine, docetaxel, and zoledronate in men with hormone-refractory prostate cancer and ha…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel [Phase 2]
A Phase 2 trial evaluating cabazitaxel plus prednisone with octreotide for castration-resistant prostate cancer previously treated with doce…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide [Phase 2]
Phase 2 trial assessing the effect of enzalutamide (MDV3100) on androgen signaling and anti-tumor activity in metastatic castration-resistan…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]
Clinical trial update shows completion of a Phase I/II study of ODX (Osteodex) in metastatic castration-resistant prostate cancer.
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: A Phase I Study of LFA102 in Japanese Patients [Phase 1]
This update notes that a Phase I trial of LFA102 in Japanese patients has been completed, evaluating castration-resistant prostate cancer an…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer [Phase 1, Phase 2]
This clinical trial update reports termination of a Phase 1/2 study of temsirolimus intended to reverse androgen insensitivity in castration…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]
Phase 2 trial evaluating saracatinib (AZD0530) in hormone-resistant/recurrent prostate cancer has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy [Phase 2]
A Phase 2 trial of itraconazole in castration-resistant prostate cancer after chemotherapy was terminated, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Radium-223 dichloride (BAY88-8223) trial in castration-resistant prostate cancer with bone metastases is no longer available.
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]
Phase 2 trial evaluating eribulin mesylate in hormone-refractory/metastatic prostate cancer. The study is completed and results were posted …
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer. [Phase 1]
A completed Phase 1 study of the AKT inhibitor AZD5363 (ipatasertib) in metastatic castration-resistant prostate cancer. The trial evaluated…
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC) [Phase 2]
Phase 2 safety and efficacy study of siltuximab in men with metastatic castration-resistant prostate cancer was terminated; results were pos…